Zim Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 110.07 | 97.16 | 91.04 |
| Operating Expense | 93.28 | 83.63 | 81.33 |
| Net Profit | 5.42 | 4.35 | 1.22 |
| Net Profit Margin | 4.92 | 4.48 | 1.34 |
| Earning Per Share | 1.11 | 0.89 | 0.25 |
| EBIDTA | 16.90 | 12.51 | 9.32 |
| Effective Tax Rate | 19.89 | 4.88 | 2.47 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 110.07 |
| Operating Expense | 93.28 |
| Net Profit | 5.42 |
| Net Profit Margin | 4.92 |
| Earning Per Share | 1.11 |
| EBIDTA | 16.90 |
| Effective Tax Rate | 19.89 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 375.64 | 365.47 | 396.53 |
| Operating Expenses Annual | 332.37 | 325.37 | 345.34 |
| Operating Profit Annual | 48.89 | 44.79 | 57.62 |
| Interest Annual | 11.39 | 6.92 | 5.58 |
| Depreciation | 18.24 | 13.08 | 13.45 |
| Net Profit Annual | 11.74 | 16.76 | 25.01 |
| Tax Annual | 5.87 | 6.28 | 10.91 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 375.64 |
| Operating Expenses Annual | 332.37 |
| Operating Profit Annual | 48.89 |
| Interest Annual | 11.39 |
| Depreciation | 18.24 |
| Net Profit Annual | 11.74 |
| Tax Annual | 5.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.17 | 1.11 | 0.54 |
| Cash Flow from Operations | 50.60 | 11.47 | 35.23 |
| Cash Flow from Investing | -41.31 | -71.94 | -35.21 |
| Cash Flow from Financing | -9.10 | 59.53 | 0.55 |
| Cash Flow at the End | 0.36 | 0.17 | 1.11 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.17 |
| Cash Flow from Operations | 50.60 |
| Cash Flow from Investing | -41.31 |
| Cash Flow from Financing | -9.10 |
| Cash Flow at the End | 0.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 13.02 | 12.26 | 14.53 |
| PBIT Margin (%) | 7.72 | 8.20 | 10.47 |
| PBT Margin (%) | 7.04 | 7.02 | 8.59 |
| Net PROFIT Margin (%) | 3.13 | 4.59 | 6.31 |
| Return On Networth / Equity (%) | 4.93 | 7.87 | 13.73 |
| Return On Networth /Employed (%) | 8.21 | 9.99 | 17.30 |
| Return On Assets (%) | 3.31 | 5.59 | 10.41 |
| Total Debt / Equity (X) | 0.48 | 0.41 | 0.32 |
| Asset Turnover Ratio (%) | 1.06 | 1.22 | 1.65 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 13.02 |
| PBIT Margin (%) | 7.72 |
| PBT Margin (%) | 7.04 |
| Net PROFIT Margin (%) | 3.13 |
| Return On Networth / Equity (%) | 4.93 |
| Return On Networth /Employed (%) | 8.21 |
| Return On Assets (%) | 3.31 |
| Total Debt / Equity (X) | 0.48 |
| Asset Turnover Ratio (%) | 1.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 185.21 | 177.22 | 115.57 |
| Total Current Assets Annual | 216.35 | 217.71 | 178.64 |
| Non Current Assets Annual | 248.04 | 224.79 | 156.23 |
| Total Shareholders Funds Annual | 244.51 | 231.95 | 194.18 |
| Total Assets Annual | 464.39 | 442.50 | 334.87 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 185.21 |
| Total Current Assets Annual | 216.35 |
| Non Current Assets Annual | 248.04 |
| Total Shareholders Funds Annual | 244.51 |
| Total Assets Annual | 464.39 |
EPS (INR)
Expected
1.00
Reported
1.01
Surprise
1.00%
Dec 2024
EPS beaten by 1.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
